These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4465436)

  • 1. [Formation of tablets with the aid of chain extensiometry. II. Methodology of formulation].
    Delacourte-Thibaut A; Devise B; Guyot JC; Traisnel M
    J Pharm Belg; 1974; 29(6):489-522. PubMed ID: 4465436
    [No Abstract]   [Full Text] [Related]  

  • 2. [Manufacture of tablets using a chain of extensiometry. III. Mathemactical and graphic study of compression cycles].
    Boniface M; Boniface B; Delacourte-Thibaut A; Devise B; Guyot JC; Moulin M
    J Pharm Belg; 1975; 30(1):39-58. PubMed ID: 1151606
    [No Abstract]   [Full Text] [Related]  

  • 3. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Formulation of tablets with the aid of chain extensiometry. Technics of study].
    Delacourte-Thibaut A; Devise B; Guyot JC; Traisnel M
    J Pharm Belg; 1974; 29(1):83-4. PubMed ID: 4831719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of formation of an hydrophilic and continuous network of starch on tablets properties. II. Repercussion on tablets characteristics, depending on conditions of the compression (author's transl)].
    Ringard J; Guyot-Hermann AM
    J Pharm Belg; 1979; 34(3):175-82. PubMed ID: 480129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Formulation of slow-release tablets. III. Lipid matrices].
    Doelker E; Buri P
    Pharm Acta Helv; 1981; 56(4-5):111-8. PubMed ID: 7255497
    [No Abstract]   [Full Text] [Related]  

  • 7. [Formulation of tablets with the aid of chain extentiometry. I. Technics of the study].
    Delacourte-Thibaut A; Devise B; Guyot JC; Traisnel M
    J Pharm Belg; 1974; 29(3):251-80. PubMed ID: 4422209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems posed by the formulation of tablets of a peptide extracted from Teskra echinops spinosus (Composees)].
    Pourrat A; Renoux R
    Ann Pharm Fr; 1976; 34(3-4):107-14. PubMed ID: 984679
    [No Abstract]   [Full Text] [Related]  

  • 9. The presence of microorganisms in some common excipients used in tablet formulation.
    Obuekwe IF; Eichie F
    Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wood flour as an auxiliary substance in tablet forming. II. Effects of wood flour on some properties of tablets].
    Kolarski K; Krówczyński L
    Acta Pol Pharm; 1970; 27(5):477-86. PubMed ID: 5501744
    [No Abstract]   [Full Text] [Related]  

  • 11. [Microcrystalline cellulose and their flow -- morphological properties modifications as an effective excpients in tablet formulation technology containing lattice established API and also dry plant extract].
    Zgoda MM; Nachajski MJ; Kołodziejczyk MK
    Polim Med; 2009; 39(1):17-30. PubMed ID: 19580170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of xylitol on the stability and morphological parameters of tablets with sorbitol made by direct tabletting of formulation components.
    Zgoda MM; Woskowicz M; Nachajski M; Haeusler O; Iwanczyk M
    Pharmazie; 2004 Aug; 59(8):651-3. PubMed ID: 15378860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular galenics. 14. The mechanism of tablet formation].
    Hütterauch R; Keiner I
    Pharmazie; 1976; 31(9):651-2. PubMed ID: 1019218
    [No Abstract]   [Full Text] [Related]  

  • 15. [Investigation on the formula of Fuyankang dispersed tablets].
    Tao HM; Wang LS; Heng DY; Xu MC
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(22):1742-4. PubMed ID: 16468368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging elevated temperature and particle size reduction to extract API from various tablet formulations.
    Nickerson B; Arikpo WB; Berry MR; Bobin VJ; Houck TL; Mansour HL; Warzeka J
    J Pharm Biomed Anal; 2008 Jun; 47(2):268-78. PubMed ID: 18280688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
    Ma Y; Li WZ; Chen DW
    Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid quantitative analysis of magnesium stearate in pharmaceutical powders and solid dosage forms by atomic absorption: method development and application in product manufacturing.
    Sugisawa K; Kaneko T; Sago T; Sato T
    J Pharm Biomed Anal; 2009 Apr; 49(3):858-61. PubMed ID: 19195812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the production and control of tablets. 8. Methods for the evaluation of basic raw materials and semifinished products].
    Chalabala M; Malý J
    Cesk Farm; 1966 Jun; 15(5):264-8. PubMed ID: 5329646
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.